Insider track record
OtherAcross 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Mulay James. Director active across 1 company, notably CG Oncology, Inc.. Cumulatively, 18 filings have been logged. Split: 0 buy · 7 sells. Total volume traded: €3.5m. History available since 5 September 2025. The latest transaction was disclosed on 10 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Mulay James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
24,165 shares@ US$75.16Common StockSEC:0001193125-26-303188:1
24,165 shares@ US$26.63Common StockSEC:0001193125-26-303188:0
654 sharesCommon StockSEC:0001684531-26-000002:0
654 sharesCommon StockSEC:0001684531-26-000002:1
1,310 sharesCommon StockSEC:0001684531-26-000002:2
1,310 sharesCommon StockSEC:0001684531-26-000002:3
15,600 shares@ US$36.630.0089% mcap19.3% of flowCommon StockSEC:0001193125-26-164013:0
15,600 shares@ US$73.010.018% mcap38.4% of flowCommon StockSEC:0001193125-26-164013:1
654 shares@ US$3.720.1% of flowCommon StockSEC:0001193125-26-110831:0
654 shares@ US$3.720.2% of flowCommon StockSEC:0001193125-26-011756:0
654 shares@ US$44.162.3% of flowCommon StockSEC:0001193125-26-011756:1
10,491 shares@ US$12.5910.7% of flowCommon StockSEC:0001193125-26-011756:2
10,491 shares@ US$52.9944.9% of flowCommon StockSEC:0001193125-26-011756:3
5,903 shares@ US$3.720.7% of flowCommon StockSEC:0001193125-25-237104:0
12,755 shares@ US$1.821.9% of flowCommon StockSEC:0001193125-25-225133:0
12,755 shares@ US$39.1940.1% of flowCommon StockSEC:0001193125-25-225133:1
19,112 shares@ US$1.821.2% of flowCommon StockSEC:0001193125-25-210015:0
27,015 shares@ US$0.600.5% of flowCommon StockSEC:0000950170-25-113556:0
About Mulay James
Mulay James is a director of CG Oncology, Inc. Across 10 total filings, the 10 sampled filings, from 2025-09-30 to 2026-06-16, show €0 of purchases and €927727 of sales, with option exercise as the most frequent transaction nature.